GIONCO DAVID (Chief Accounting Officer) sold 0.6% of their position (1.38K shares) of STEMLINE THERAPEUTICS INC on the open market
Open‑market sale worth $15.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/8/2019ACC: 0001104659-19-013683
Officer· Chief Accounting Officer
Since Feb 2019
-1.38K
Net shares
Net seller
$15.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.38K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.38K
Price / share
$11.32
Trade value
$15.63K
% of position
0.6%
3/7/2019
240.34K→238.96K
Total
Net shares
−1.38K
Net value
-$15.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/7/2019 | S · Sale | −1.38K | $11.32 | $15.63K | 0.6% | 240.34K | 238.96K |
| Total | −1.38K | -$15.63K | ||||||
Derivative Transactions0
No derivative transactions reported